当前位置: X-MOL 学术Eur. J. Nucl. Med. Mol. Imaging › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.
European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2019-09-16 , DOI: 10.1007/s00259-019-04524-z
Wojciech Cytawa 1, 2 , Anna Katharina Seitz 3 , Stefan Kircher 4 , Kazuhito Fukushima 2 , Johannes Tran-Gia 2 , Andreas Schirbel 2 , Tomasz Bandurski 5 , Piotr Lass 1 , Markus Krebs 3 , Wojciech Połom 6 , Marcin Matuszewski 6 , Hans-Jürgen Wester 7 , Andreas K Buck 2 , Hubert Kübler 3 , Constantin Lapa 2
Affiliation  

The present study is based on a retrospective analysis of Gallium-68 (68Ga)-labelled prostate-specific membrane antigen (68Ga-PSMA I&T) PET/CT performed in newly diagnosed, treatment-naïve prostate cancer (PCa) patients prior to definitive treatment.

中文翻译:

68Ga-PSMA I&T PET / CT用于前列腺癌的主要分期。

本研究基于回顾性分析镓-68(68 Ga)标记的前列腺特异性膜抗原(68 Ga-PSMA I&T)PET / CT,在新诊断,未经治疗的前列腺癌(PCa)患者之前进行明确的治疗。
更新日期:2019-11-30
down
wechat
bug